| Meghan Galer, MD | |
|
1601 12th St Ste 3, Columbus, GA 31906-5725 | |
| (706) 365-0365 | |
| Not Available |
| Full Name | Meghan Galer |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1601 12th St Ste 3, Columbus, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619276995 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 80367 (Georgia) | Secondary |
| 207P00000X | Emergency Medicine | 80367 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Meghan Galer, MD 820 Peachtree Dr, Columbus, GA 31906-3518 Ph: (706) 365-0365 | Meghan Galer, MD 1601 12th St Ste 3, Columbus, GA 31906-5725 Ph: (706) 365-0365 |
News Archive
Doctors are running out of treatments for today's trauma victims and critically ill patients because of infections due to drug resistant microbes - even after resorting to using medicines thrown out 20 years ago because of severe side effects, scientists heard at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.
Infection is a serious complication of intravenous drug abuse and a major cause of illness and death among intravenous drug users. As the national problem of opioid abuse, including of heroin, continues to grow, new research by clinicians at Beth Israel Deaconess Medical Center and the VA Boston Healthcare System, published today in the May issue of the journal Health Affairs, offers new insights into the significant impact of the trend on opioid-related hospitalizations, infectious complications and health care costs.
An active charity supporter has been nominated for Breast Cancer Campaign's 'Fundraiser of the Year' award after raising more than £7,500 to help the charity continue funding vital breast cancer research.
A DNA-level biomarker (MGMT promoter methylation) can be used to help predict survival outcomes in patients with high-risk, low-grade gliomas, according to a new study conducted through the NRG Oncology/RTOG collaborative clinical trials group and led by scientists at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced miravirsen (SPC3649), the first microRNA-targeted drug to enter clinical trials, into Phase 2 studies to assess the safety and tolerability of the drug in treatment-naive patients infected with the Hepatitis C virus.
› Verified 2 days ago
Dr. Jonathan Thomas, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8400 Veterans Pkwy Apt 814, Columbus, GA 31909 Phone: 814-504-4211 | |
Dr. Jacqueline Akua Owusu, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2022 10th Ave Ste B, Columbus, GA 31901 Phone: 706-507-9407 Fax: 706-507-9408 | |
Mr. David P. Smith, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2122 Manchester Expressway, Columbus, GA 31904 Phone: 706-596-4000 | |
John R Corbin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2122 Manchester Expressway, Columbus, GA 31904 Phone: 706-596-4000 | |
Dr. Kennon A Mclendon, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 710 Center St, Columbus, GA 31901 Phone: 706-571-1200 | |
Michael David Hagues, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2122 Manchester Expressway, Columbus, GA 31904 Phone: 706-596-4000 | |
Gehrig Leonard Harris Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7093 Haddonfield Ct, Columbus, GA 31904 Phone: 337-336-0423 |